PMID- 32768653 OWN - NLM STAT- MEDLINE DCOM- 20201102 LR - 20201102 IS - 1879-3169 (Electronic) IS - 0378-4274 (Linking) VI - 333 DP - 2020 Oct 15 TI - Methamphetamine induced neuroinflammation in mouse brain and microglial cell line BV2: Roles of the TLR4/TRIF/Peli1 signaling axis. PG - 150-158 LID - S0378-4274(20)30346-5 [pii] LID - 10.1016/j.toxlet.2020.07.028 [doi] AB - Methamphetamine (Meth), a highly addictive drug, can induce irreversible neuronal damage and cause neuropsychiatric and cognitive disorders. Meth's effects on modulating microglial neuroimmune functions and eliciting neuroinflammation have attracted considerable attention in recent years. Recent evident of the effect of the non-dependent domain containing adaptor inducing interferon (TRIF)/Pellino1 (Peli1) signaling axis on pro-inflammatory cytokine production provides novel clues for inflammation. Therefore, our study investigated Meth-induced neurotoxicity from a neuropathological perspective by examining TLR4-TRIF-Peli1 axis signaling activation. Meth significantly activated microglia accompanied by marked increase of TLR4 and TRIF expression, NF-kB and MAPK pathways activation and the production of IL-1beta, TNF-alpha and IL-6. Peli1 was involved in Meth-mediated neuroinflammation and knockdown of Peli1 strongly reversed NF-kB and MAPK pathways activation and pro-inflammatory cytokine excretion. Intriguingly, Peli1 upregulation induced by Meth was dependent on TRIF rather than the myloid differentiation factor 88 (MyD88) pathway, since the silencing of TRIF significantly suppressed Meth-induced Peli1 upregulation, while MyD88 knockdown had no obvious impact. Additionally, an in vivo study verified TLR4-TRIF-Peli1 axis activation and an enhanced level of downstream cytokine expression in the cortex after Meth treatment. Therefore, these findings provide new insight regarding the specific contributions of the TRIF-Peli1 pathway to Meth-mediated neuroinflammation. CI - Copyright (c) 2020 Elsevier B.V. All rights reserved. FAU - Yang, Tingyu AU - Yang T AD - Key Laboratory of Modern Toxicology (NJMU), Ministry of Education, Department of Toxicology, School of Public Health, Nanjing Medical University, 818 Tianyuan East Road, Nanjing, Jiangsu, 211166, China. FAU - Zang, Songsong AU - Zang S AD - Key Laboratory of Modern Toxicology (NJMU), Ministry of Education, Department of Toxicology, School of Public Health, Nanjing Medical University, 818 Tianyuan East Road, Nanjing, Jiangsu, 211166, China. FAU - Wang, Yixin AU - Wang Y AD - Key Laboratory of Modern Toxicology (NJMU), Ministry of Education, Department of Toxicology, School of Public Health, Nanjing Medical University, 818 Tianyuan East Road, Nanjing, Jiangsu, 211166, China. FAU - Zhu, Yuanhui AU - Zhu Y AD - Key Laboratory of Modern Toxicology (NJMU), Ministry of Education, Department of Toxicology, School of Public Health, Nanjing Medical University, 818 Tianyuan East Road, Nanjing, Jiangsu, 211166, China. FAU - Jiang, Lei AU - Jiang L AD - Department of Emergency, The First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing, Jiangsu, 210029, China. FAU - Chen, Xufeng AU - Chen X AD - Department of Emergency, The First Affiliated Hospital of Nanjing Medical University, 300 Guangzhou Road, Nanjing, Jiangsu, 210029, China. FAU - Zhang, Xiaobao AU - Zhang X AD - Department of Anesthesiology, The First People's Hospital of Lianyungang, Lianyungang, China. FAU - Cheng, Jie AU - Cheng J AD - Key Laboratory of Modern Toxicology (NJMU), Ministry of Education, Department of Toxicology, School of Public Health, Nanjing Medical University, 818 Tianyuan East Road, Nanjing, Jiangsu, 211166, China. FAU - Gao, Rong AU - Gao R AD - Key Laboratory of Modern Toxicology (NJMU), Ministry of Education, Department of Toxicology, School of Public Health, Nanjing Medical University, 818 Tianyuan East Road, Nanjing, Jiangsu, 211166, China. FAU - Xiao, Hang AU - Xiao H AD - Key Laboratory of Modern Toxicology (NJMU), Ministry of Education, Department of Toxicology, School of Public Health, Nanjing Medical University, 818 Tianyuan East Road, Nanjing, Jiangsu, 211166, China. FAU - Wang, Jun AU - Wang J AD - Key Laboratory of Modern Toxicology (NJMU), Ministry of Education, Department of Toxicology, School of Public Health, Nanjing Medical University, 818 Tianyuan East Road, Nanjing, Jiangsu, 211166, China; China International Cooperation Center for Environment and Human Health, Nanjing Medical University, 818 Tianyuan East Road, Nanjing, Jiangsu, 211166, China. Electronic address: wangjun@njmu.edu.cn. LA - eng PT - Journal Article DEP - 20200805 PL - Netherlands TA - Toxicol Lett JT - Toxicology letters JID - 7709027 RN - 0 (Adaptor Proteins, Vesicular Transport) RN - 0 (Central Nervous System Stimulants) RN - 0 (Cytokines) RN - 0 (Nuclear Proteins) RN - 0 (RNA, Small Interfering) RN - 0 (TICAM-1 protein, mouse) RN - 0 (Tlr4 protein, mouse) RN - 0 (Toll-Like Receptor 4) RN - 44RAL3456C (Methamphetamine) RN - EC 2.3.2.27 (Ubiquitin-Protein Ligases) RN - EC 6.3.2.- (Peli1 protein, mouse) SB - IM MH - Adaptor Proteins, Vesicular Transport/genetics/*metabolism MH - Animals MH - Brain/*drug effects/immunology/metabolism MH - Cell Culture Techniques MH - Cell Line MH - Central Nervous System Stimulants/*toxicity MH - Cytokines/genetics MH - Gene Expression/drug effects MH - Gene Knockdown Techniques MH - Male MH - Methamphetamine/*toxicity MH - Mice, Inbred C57BL MH - Microglia/*drug effects/immunology/metabolism MH - Nuclear Proteins/genetics/*metabolism MH - RNA, Small Interfering/genetics MH - Signal Transduction MH - Toll-Like Receptor 4/genetics/*metabolism MH - Ubiquitin-Protein Ligases/genetics/*metabolism MH - Up-Regulation OTO - NOTNLM OT - NF-kB and MAPK pathways OT - TRIF-Peli1 axis OT - methamphetamine OT - neuroinflammation COIS- Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. EDAT- 2020/08/10 06:00 MHDA- 2020/11/03 06:00 CRDT- 2020/08/10 06:00 PHST- 2020/03/30 00:00 [received] PHST- 2020/06/29 00:00 [revised] PHST- 2020/07/26 00:00 [accepted] PHST- 2020/08/10 06:00 [pubmed] PHST- 2020/11/03 06:00 [medline] PHST- 2020/08/10 06:00 [entrez] AID - S0378-4274(20)30346-5 [pii] AID - 10.1016/j.toxlet.2020.07.028 [doi] PST - ppublish SO - Toxicol Lett. 2020 Oct 15;333:150-158. doi: 10.1016/j.toxlet.2020.07.028. Epub 2020 Aug 5.